IKT Inhibikase Therapeutics, Inc.

NASDAQ

$2.06

Inhibikase Therapeutics, Inc. (IKT) Earnings News

Earnings press releases, previews and reviews for Inhibikase Therapeutics, Inc. (IKT), newest first.

Tuesday August 11, 2026 4:01 PM ET

Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity

Tuesday May 12, 2026 4:01 PM ET

Inhibikase Therapeutics Announces First Quarter 2026 Financial Results and Highlights Recent Activity